Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin for Weight Loss and Metabolic Health
NCT03180489Phase 2Completed
- Start
- May 2017
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dapagliflozin in obesity, Overweight. Started May 2017; status: completed.
02
Drugs
dapagliflozin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT03180489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03180489.